Topics - Drug Development
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published October 2, 2012
Gains rights to ASP015K for immune-mediated inflammatory diseases Read More »
Published October 1, 2012
Aims to improve health outcomes Read More »
Published October 1, 2012
Will work to develop three clinical candidates Read More »
Published September 28, 2012
Invests $32 million for research and clinical production Read More »
Published September 26, 2012
Transitions oncology program into preclinical profiling Read More »
Published September 25, 2012
Alliance to offer a range of services for protein-based drug conjugates Read More »
Published September 24, 2012
Expands pain management portfolio Read More »
By Gil Roth
Published September 19, 2012
Will manage and operate Small Molecule Repository Read More »
Published September 18, 2012
To focus on early-stage opportunities and collaborations Read More »
Published September 14, 2012
Will work to enhance allergy and asthma research Read More »
Published September 11, 2012
To develop autoimmune drug for Chinese market Read More »
By Gil Y. Roth, Contract Pharma
Published September 6, 2012
Catching up with the president of Development & Clinical Services Read More »
Published September 6, 2012
Abbott’s RealTime CMV assay to monitor patients Read More »
By Tom Spurgeon, Contract Pharma
Published September 6, 2012
Fortune and opportunity in a burgeoning class of therapies Read More »
Published August 30, 2012
To develop and commercialize daratumumab Read More »
